Literature DB >> 12699404

Cytokine-based immunointervention in the treatment of autoimmune diseases.

L Adorini1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12699404      PMCID： PMC1808696          DOI： 10.1046/j.1365-2249.2003.02144.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  98 in total

Review 1.  Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.

Authors:  Gillian M Keating; Caroline M Perry
Journal:  BioDrugs       Date:  2002       Impact factor: 5.807

Review 2.  TGF-beta: receptors, signaling pathways and autoimmunity.

Authors:  Wanjun Chen; Sharon M Wahl
Journal:  Curr Dir Autoimmun       Date:  2002

Review 3.  Comparative assessment of immunomodulating therapies for relapsing-remitting multiple sclerosis.

Authors:  Omar Khan; Rana Zabad; Christina Caon; Marina Zvartau-Hind; Alexandros Tselis; Robert Lisak
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

4.  IL-4-deficient mice develop less acute but more chronic relapsing collagen-induced arthritis.

Authors:  Lars Svensson; Kutty Selva Nandakumar; Asa Johansson; Liselotte Jansson; Rikard Holmdahl
Journal:  Eur J Immunol       Date:  2002-10       Impact factor: 5.532

Review 5.  Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.

Authors:  Christine R Culy; Gillian M Keating
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 6.  Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept.

Authors:  Roy Fleischmann; Imran Iqbal; Pallavi Nandeshwar; Andres Quiceno
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

7.  IL-10 regulates murine lupus.

Authors:  Zhinan Yin; Gul Bahtiyar; Na Zhang; Lanzhen Liu; Ping Zhu; Marie E Robert; Jennifer McNiff; Michael P Madaio; Joe Craft
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

Review 8.  Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage.

Authors:  S B Abramson; A Amin
Journal:  Rheumatology (Oxford)       Date:  2002-09       Impact factor: 7.580

9.  Induced disruption of the transforming growth factor beta type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable.

Authors:  Per Levéen; Jonas Larsson; Mats Ehinger; Corrado M Cilio; Martin Sundler; Lottie Jansson Sjöstrand; Rikard Holmdahl; Stefan Karlsson
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

Review 10.  Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases.

Authors:  Luciano Adorini
Journal:  Int Immunopharmacol       Date:  2002-06       Impact factor: 4.932
View more
  13 in total

1.  Pathognomonic genetic expression profile within peripheral blood mononuclear cells of rheumatic heart disease patients.

Authors:  M Iqbal Baba; Deepak Kaul; Anil Grover
Journal:  Mol Cell Biochem       Date:  2006-06-02       Impact factor: 3.396

Review 2.  Control of autoimmune inflammation by celastrol, a natural triterpenoid.

Authors:  Shivaprasad H Venkatesha; Steven Dudics; Brian Astry; Kamal D Moudgil
Journal:  Pathog Dis       Date:  2016-07-11       Impact factor: 3.166

Review 3.  Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential.

Authors:  Charlotte Spitz; Holger Winkels; Christina Bürger; Christian Weber; Esther Lutgens; Göran K Hansson; Norbert Gerdes
Journal:  Cell Mol Life Sci       Date:  2015-10-30       Impact factor: 9.261

4.  The complement system plays a critical role in the development of experimental autoimmune anterior uveitis.

Authors:  Purushottam Jha; Jeong-Hyeon Sohn; Qin Xu; Hiroki Nishihori; Yali Wang; Saori Nishihori; Balasubramanian Manickam; Henry J Kaplan; Puran S Bora; Nalini S Bora
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-03       Impact factor: 4.799

Review 5.  Current prospects of type II interferon γ signaling and autoimmunity.

Authors:  Daniel S Green; Howard A Young; Julio C Valencia
Journal:  J Biol Chem       Date:  2017-06-26       Impact factor: 5.157

6.  Interleukin-4 supports interleukin-12-induced proliferation and interferon-gamma secretion in human activated lymphoblasts and T helper type 1 cells.

Authors:  Martin A Kriegel; Theresa Tretter; Norbert Blank; Martin Schiller; Christoph Gabler; Silke Winkler; Joachim R Kalden; Hanns-Martin Lorenz
Journal:  Immunology       Date:  2006-06-06       Impact factor: 7.397

7.  Relationships between Cytokine Levels and Disease Parameters during the Development of a Collagen-induced Arthritis Model in Cynomolgus Macaques (Macaca fascicularis).

Authors:  Eun Wha Choi; Sungjoo Kim
Journal:  Comp Med       Date:  2019-05-08       Impact factor: 0.982

8.  Regulation of autoimmune arthritis by the pro-inflammatory cytokine interferon-gamma.

Authors:  Eugene Y Kim; Howard H Chi; Mohammed Bouziane; Amitabh Gaur; Kamal D Moudgil
Journal:  Clin Immunol       Date:  2008-02-13       Impact factor: 3.969

Review 9.  Immunotherapy of autoimmunity and cancer: the penalty for success.

Authors:  Rachel R Caspi
Journal:  Nat Rev Immunol       Date:  2008-12       Impact factor: 53.106

10.  Interleukin-10 overexpression promotes Fas-ligand-dependent chronic macrophage-mediated demyelinating polyneuropathy.

Authors:  Dru S Dace; Aslam A Khan; Jennifer L Stark; Jennifer Kelly; Anne H Cross; Rajendra S Apte
Journal:  PLoS One       Date:  2009-09-22       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.